UW Medicine is seeking a qualified and experienced vendor to support its Acute Hospital Care at Home (AHCH) program through consultative services, remote patient monitoring technology and interfaces, information technology, staffing, logistics coordination, service providers, and delivery of acute hospital-level care in patients’ homes. The program must comply with CMS Acute Hospital Care at Home requirements.
Current deadline and amendment status
The current publicly indexed close date is September 22, 2026. Current Washington procurement indexing identifies RFP 9589 and shows an amendment dated July 22, 2026. Older mirrors carried earlier August dates, so Atlas treats September 22 as the current amended close date. The exact closing time, time zone, and controlling submission mechanics must still be confirmed from the current WEBS solicitation package and all addenda.
Clinical and technology scope
The opportunity is unusually aligned with connected home-based clinical care. Accessible current solicitation summaries describe an end-to-end AHCH model that includes remote patient monitoring, an in-home technology kit with tablet and clinical peripherals, secure monitoring, Epic integration using HL7/API interfaces, IT support, pharmacy, infusion, respiratory services, diagnostics, durable medical equipment, therapy, social work, transportation, emergency response, and 24/7 command-center connectivity. Public summaries also describe a two-year fixed-price term with extension options that could reach nine years total.
Atlas and N9+ analysis
Atlas Opportunity Score: 98/100. N9+ Direct Vendor Fit: 98/100 — HIGH FIT. The strongest N9+ role is the connected remote-examination and clinical-peripheral layer within UW Medicine’s in-home technology stack, extending the model beyond video-only telehealth while supporting remote vitals and physical-exam data capture.
Current path classification: Path C provisional, not confirmed Path A. The broader procurement includes substantial clinical staffing, pharmacy, infusion, diagnostics, logistics and other hospital-at-home services outside Dr. Miltie’s standalone scope. Current evidence therefore does not establish that Dr. Miltie can satisfy the entire procurement without a partner. The strongest defensible capture strategy is to position Dr. Miltie/N9+ as the technology and connected-exam component of a compliant prime or consortium unless the controlling RFP confirms a viable direct no-partner structure.
Funding and response control
The accessible public solicitation does not disclose an authoritative contract ceiling. Third-party budget estimates are not treated as official funding amounts. Current public summaries reference a required Excel pricing response and projected admission volumes, but Atlas will not use estimated values as the Deal Amount or official contract value.
Required next action
Retrieve the current Washington WEBS RFP 9589 solicitation and every addendum, including the July 22 amendment, then confirm the exact closing time/time zone, response forms and pricing workbook, mandatory qualifications, references, insurance/security requirements, submission mechanics, teaming/subcontracting rules, and complete technical/interface requirements. Map N9+ precisely to the in-home kit, clinical peripherals, remote monitoring, Epic/interface and support requirements before final response production.